Multiple ligand binding sites on domain seven of human complement factor H

Eleni Giannakis, Dean A. Male, Rebecca J. Ormsby, Carolyn Mold, T. Sakari Jokiranta, Shoba Ranganathan, David L. Gordon

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Foreign particles and damaged host cells can activate the complement system leading to their destruction by the host defense system. Factor H (fH) plays a vital role in restricting complement activation on host cells through interactions with polyanions such as heparin, while allowing activation to proceed on foreign surfaces. Complement activation by damaged host cells is also down regulated by fH, which is localized to injured areas through interactions with C-reactive protein (CRP). A number of pathogens have developed mechanisms by which they can also bind fH and thus exploit its protective properties. One such organism is Group A Streptococcus (GAS) which mediates fH binding via its surface expressed M-protein. fH consists of 20 conserved short consensus repeat (SCR) units and mutagenesis studies indicate that the seventh repeat is responsible for interactions with heparin, CRP and M-protein. We recently performed molecular modelling of fH SCR 7 and identified a cluster of positively charged residues on one face of the domain. By alanine replacement mutagenesis, we demonstrated that these residues are involved in heparin, CRP and M protein binding, which indicates that there is a common site within fH SCR 7 responsible for multiple ligand recognition.

LanguageEnglish
Pages433-443
Number of pages11
JournalInternational Immunopharmacology
Volume1
Issue number3
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Complement Factor H
Binding Sites
Ligands
C-Reactive Protein
Heparin
Complement Activation
Mutagenesis
human complement factor H
Streptococcus
Protein Binding
Cell Communication
Alanine
Proteins

Keywords

  • C-reactive protein
  • Complement
  • Factor H
  • Heparin
  • Streptococcal M-protein

Cite this

Giannakis, E., Male, D. A., Ormsby, R. J., Mold, C., Jokiranta, T. S., Ranganathan, S., & Gordon, D. L. (2001). Multiple ligand binding sites on domain seven of human complement factor H. International Immunopharmacology, 1(3), 433-443. https://doi.org/10.1016/S1567-5769(00)00040-0
Giannakis, Eleni ; Male, Dean A. ; Ormsby, Rebecca J. ; Mold, Carolyn ; Jokiranta, T. Sakari ; Ranganathan, Shoba ; Gordon, David L. / Multiple ligand binding sites on domain seven of human complement factor H. In: International Immunopharmacology. 2001 ; Vol. 1, No. 3. pp. 433-443.
@article{f160ec095541433593af99454f6aad2b,
title = "Multiple ligand binding sites on domain seven of human complement factor H",
abstract = "Foreign particles and damaged host cells can activate the complement system leading to their destruction by the host defense system. Factor H (fH) plays a vital role in restricting complement activation on host cells through interactions with polyanions such as heparin, while allowing activation to proceed on foreign surfaces. Complement activation by damaged host cells is also down regulated by fH, which is localized to injured areas through interactions with C-reactive protein (CRP). A number of pathogens have developed mechanisms by which they can also bind fH and thus exploit its protective properties. One such organism is Group A Streptococcus (GAS) which mediates fH binding via its surface expressed M-protein. fH consists of 20 conserved short consensus repeat (SCR) units and mutagenesis studies indicate that the seventh repeat is responsible for interactions with heparin, CRP and M-protein. We recently performed molecular modelling of fH SCR 7 and identified a cluster of positively charged residues on one face of the domain. By alanine replacement mutagenesis, we demonstrated that these residues are involved in heparin, CRP and M protein binding, which indicates that there is a common site within fH SCR 7 responsible for multiple ligand recognition.",
keywords = "C-reactive protein, Complement, Factor H, Heparin, Streptococcal M-protein",
author = "Eleni Giannakis and Male, {Dean A.} and Ormsby, {Rebecca J.} and Carolyn Mold and Jokiranta, {T. Sakari} and Shoba Ranganathan and Gordon, {David L.}",
year = "2001",
doi = "10.1016/S1567-5769(00)00040-0",
language = "English",
volume = "1",
pages = "433--443",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "3",

}

Giannakis, E, Male, DA, Ormsby, RJ, Mold, C, Jokiranta, TS, Ranganathan, S & Gordon, DL 2001, 'Multiple ligand binding sites on domain seven of human complement factor H', International Immunopharmacology, vol. 1, no. 3, pp. 433-443. https://doi.org/10.1016/S1567-5769(00)00040-0

Multiple ligand binding sites on domain seven of human complement factor H. / Giannakis, Eleni; Male, Dean A.; Ormsby, Rebecca J.; Mold, Carolyn; Jokiranta, T. Sakari; Ranganathan, Shoba; Gordon, David L.

In: International Immunopharmacology, Vol. 1, No. 3, 2001, p. 433-443.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Multiple ligand binding sites on domain seven of human complement factor H

AU - Giannakis, Eleni

AU - Male, Dean A.

AU - Ormsby, Rebecca J.

AU - Mold, Carolyn

AU - Jokiranta, T. Sakari

AU - Ranganathan, Shoba

AU - Gordon, David L.

PY - 2001

Y1 - 2001

N2 - Foreign particles and damaged host cells can activate the complement system leading to their destruction by the host defense system. Factor H (fH) plays a vital role in restricting complement activation on host cells through interactions with polyanions such as heparin, while allowing activation to proceed on foreign surfaces. Complement activation by damaged host cells is also down regulated by fH, which is localized to injured areas through interactions with C-reactive protein (CRP). A number of pathogens have developed mechanisms by which they can also bind fH and thus exploit its protective properties. One such organism is Group A Streptococcus (GAS) which mediates fH binding via its surface expressed M-protein. fH consists of 20 conserved short consensus repeat (SCR) units and mutagenesis studies indicate that the seventh repeat is responsible for interactions with heparin, CRP and M-protein. We recently performed molecular modelling of fH SCR 7 and identified a cluster of positively charged residues on one face of the domain. By alanine replacement mutagenesis, we demonstrated that these residues are involved in heparin, CRP and M protein binding, which indicates that there is a common site within fH SCR 7 responsible for multiple ligand recognition.

AB - Foreign particles and damaged host cells can activate the complement system leading to their destruction by the host defense system. Factor H (fH) plays a vital role in restricting complement activation on host cells through interactions with polyanions such as heparin, while allowing activation to proceed on foreign surfaces. Complement activation by damaged host cells is also down regulated by fH, which is localized to injured areas through interactions with C-reactive protein (CRP). A number of pathogens have developed mechanisms by which they can also bind fH and thus exploit its protective properties. One such organism is Group A Streptococcus (GAS) which mediates fH binding via its surface expressed M-protein. fH consists of 20 conserved short consensus repeat (SCR) units and mutagenesis studies indicate that the seventh repeat is responsible for interactions with heparin, CRP and M-protein. We recently performed molecular modelling of fH SCR 7 and identified a cluster of positively charged residues on one face of the domain. By alanine replacement mutagenesis, we demonstrated that these residues are involved in heparin, CRP and M protein binding, which indicates that there is a common site within fH SCR 7 responsible for multiple ligand recognition.

KW - C-reactive protein

KW - Complement

KW - Factor H

KW - Heparin

KW - Streptococcal M-protein

UR - http://www.scopus.com/inward/record.url?scp=0035093955&partnerID=8YFLogxK

U2 - 10.1016/S1567-5769(00)00040-0

DO - 10.1016/S1567-5769(00)00040-0

M3 - Article

VL - 1

SP - 433

EP - 443

JO - International Immunopharmacology

T2 - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 3

ER -